Key Questions
What were the main topics at ESC Congress 2020?
ESC Congress 2020 covered general cardiology, cardiac surgery, heart failure, interventional cardiology, and atrial fibrillation. The congress presented breakthrough studies and new guidelines in these areas.
How did COVID-19 affect the ESC Congress 2020?
ESC Congress 2020 was held virtually for the first time due to the COVID-19 pandemic. Despite this change, the congress attracted 116,000 delegates from 211 countries and presented cutting-edge cardiovascular science.
What new ESC guidelines were presented in 2020?
ESC presented new guidelines on atrial fibrillation, acute coronary syndromes without persistent ST-segment elevation, adult congenital heart diseases, and sports cardiology for patients with cardiovascular disease.
What was the EMPEROR-Reduced trial about?
The EMPEROR-Reduced trial showed that empagliflozin, an antidiabetic drug, reduced cardiovascular death and hospitalization in patients with heart failure and reduced ejection fraction when added to standard therapy.
What did the EXPLORER-HCM trial reveal?
The EXPLORER-HCM trial found that mavacamten, a new drug, improved exercise capacity, heart function, and symptoms in patients with obstructive hypertrophic cardiomyopathy.
How has BMC Cardiovascular Disorders changed?
BMC Cardiovascular Disorders updated to seven journal sections, including Arrhythmias and Electrophysiology, CV Surgery, Coronary Artery Disease, Epidemiology and Digital Health, Hypertension and Vascular Biology, Primary Prevention and CV Risk, and Structural Diseases, Heart Failure, and Congenital Disorders.
